+ Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.

Slides:



Advertisements
Similar presentations
CRITICAL APPRAISAL ON AN ARTICLE ABOUT PROGNOSIS
Advertisements

Introduction to EVIDENCE-BASED MEDICINE
EUROCHIP PILOT STUDIES. Collection of detailed clinical information for specific tumours Describing and comparing care in representative samples of cancer.
Making evidence more accessible using pictures
Is it True? Evaluating Research about Diagnostic Tests
Critically Evaluating the Evidence: diagnosis, prognosis, and screening Elizabeth Crabtree, MPH, PhD (c) Director of Evidence-Based Practice, Quality Management.
Evaluation of Diagnostic Test Studies
Journal Club Alcohol and Health: Current Evidence September–October 2006.
Journal Club Alcohol and Health: Current Evidence July–August 2005.
Journal Club Alcohol and Health: Current Evidence March-April 2006.
Journal Club Alcohol and Health: Current Evidence September-October 2005.
Baye’s Rule and Medical Screening Tests. Baye’s Rule Baye’s Rule is used in medicine and epidemiology to calculate the probability that an individual.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2010.
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U. Evidence-based medicine.
Critiquing for Evidence-based Practice: Diagnostic and Screening Tests M8120 Columbia University Fall 2001 Suzanne Bakken, RN, DNSc.
Are the results valid? Was the validity of the included studies appraised?
HOW TO READ AN ARTICLE ABOUT A DIAGNOSTIC TEST Chitkara MB, Boykan R, Messina C Stony Brook Long Island Children’s Hospital.
Statistics in Screening/Diagnosis
The Nature of Disease.
Multiple Choice Questions for discussion
Intervention Studies Principles of Epidemiology Lecture 10 Dona Schneider, PhD, MPH, FACE.
Diagnosis Articles Much Thanks to: Rob Hayward & Tanya Voth, CCHE.
1 Lecture 2 Screening and diagnostic tests Normal and abnormal Validity: “gold” or criterion standard Sensitivity, specificity, predictive value Likelihood.
DEB BYNUM, MD AUGUST 2010 Evidence Based Medicine: Review of the basics.
EBM --- Journal Reading Presenter :李政鴻 Date : 2005/10/26.
Vanderbilt Sports Medicine How to practice and teach EBM Chapter 3 May 3, 2006.
Evidence Based Medicine Workshop Diagnosis March 18, 2010.
Previous Lecture: Data types and Representations in Molecular Biology.
PHARM 3823 Health & Biostats Evidence-Based Medicine or Please Pass the PICO… Frederic Murray Assistant Professor MLIS, University of British Columbia.
EBCP. Random vs Systemic error Random error: errors in measurement that lead to measured values being inconsistent when repeated measures are taken. Ie:
EVIDENCE ABOUT DIAGNOSTIC TESTS Min H. Huang, PT, PhD, NCS.
Division of Population Health Sciences Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn Diagnostic accuracy of the ID-Migraine:
Diagnosis: EBM Approach Michael Brown MD Grand Rapids MERC/ Michigan State University.
CRITICAL APPRAISAL OF ARTICLE ON HARM. Among patients with acute rheumatic fever, will administration of non steroidal anti- inflammatory drugs have adverse.
Appraising A Diagnostic Test
Evidence-Based Medicine Diagnosis Component 2 / Unit 5 1 Health IT Workforce Curriculum Version 1.0 /Fall 2010.
Wipanee Phupakdi, MD September 15, Overview  Define EBM  Learn steps in EBM process  Identify parts of a well-built clinical question  Discuss.
1. Statistics Objectives: 1.Try to differentiate between the P value and alpha value 2.When to perform a test 3.Limitations of different tests and how.
Prediction statistics Prediction generally True and false, positives and negatives Quality of a prediction Usefulness of a prediction Prediction goes Bayesian.
This material was developed by Oregon Health & Science University, funded by the Department of Health and Human Services, Office of the National Coordinator.
Section C Maranion – Mendoza. Subjective Pertinent PositivePertinent Negative 28 y/o female CC: Hemoptysis Chronic cough No weight change No change in.
Making epidemiological evidence more accessible using pictures Rod Jackson Updated November 09.
Critical Appraisal (CA) I Prepared by Dr. Hoda Abd El Azim.
Quality control & Statistics. Definition: it is the science of gathering, analyzing, interpreting and representing data. Example: introduction a new test.
Decision Analytic Approaches for Evidence-Based Practice M8120 Fall 2001 Suzanne Bakken, RN, DNSc, FAAN School of Nursing & Department of Medical Informatics.
CLINICAL EPIDEMIOLOGY III: JOURNAL APPRAISAL Group 3 February 11, 2010.
Diagnostic Test Characteristics: What does this result mean
EBM --- Journal Reading Presenter :呂宥達 Date : 2005/10/27.
Journal club Diagnostic accuracy of Urinalysis for UTI in Infants
EBM --- Journal Reading Presenter :傅斯誠 Date : 2005/10/26.
Validation and Refinement of a Prediction Rule to Identify Children at Low Risk for Acute Appendicitis Kharbanda AB, Dudley NC, Bajaj L, et al; Pediatric.
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
Clinical Decision on A Diagnostic Test. Clinical Question In a middle aged man with primary gout and azotemia, can a urine uric acid to creatinine ratio.
PTP 560 Research Methods Week 12 Thomas Ruediger, PT.
EBM --- Journal Reading Presenter :黃美琴 Date : 2005/10/27.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Diagnosis Recitation. The Dilemma At the conclusion of my “diagnosis” presentation during the recent IAPA meeting, a gentleman from the audience asked.
Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients Thrombosis Research (2008)
When is the post-test probability sufficient for decision-making?
Choosing Wisely : Radiology Perspective
Does This Adult Patient Have Acute Meningitis?
How do we delay disease progress once it has started?
Diagnosis II Dr. Brent E. Faught, Ph.D. Assistant Professor
Refining Probability Test Informations Vahid Ashoorion MD. ,MSc,
Diagnosis General Guidelines:
I.M. Sechenov First Moscow State Medical University
Evidence Based Practice
Evidence Based Diagnosis
Presentation transcript:

+ Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class September 15, 2008

+ Salient Features R.E. 25/F Presenting with R flank pain radiating to the R inguinal area, hematuria, and frequency

+ Differential Diagnosis Urolithiasis (pretest probability of 60%) R flank pain radiating to the R inguinal area Hematuria Frequency Acute Uncomplicated Cystitis (pretest probability of 30%) Hematuria Frequency Acute Appendicitis (pretest probability of 2%) R flank pain (a remote possibility)

+ Review Decision threshold Based on your own clinical judgment Pretest Probability Based on prevalence studies

+ UROLITHIASIS Decision Threshold: 5%-75% 5% (lower limit) – below which, send pt home and do nothing 75% (upper limit) – start treatment Pretest Probability: 60% This falls in between 5 and 75% so we cannot start treatment right away nor send the patient home. Therefore, we need further diagnostic testing. 0% 5%75% 60% Urolithiasis

+ ACUTE UNCOMPLICATED CYSTITIS Decision Threshold: 5%-40% 5% (lower limit) – below which, send pt home and do nothing 40% (upper limit) – start treatment (Ofloxacin 200mg BID x 3 days) Pretest Probability: 30% This falls in between 5 and 40% so we cannot start treatment right away nor send the patient home. Therefore, we need further diagnostic testing. 0% 5%40% 30% Acute Uncomplicated Cystitis

+ ACUTE APPENDICITIS Decision Threshold: 5%-90% 5% (lower limit) – below which, send pt home and do nothing 90% (upper limit) – start treatment (appendectomy) Pretest Probability: 2% There is no need for further diagnostic testing in this case because it is below our 5% limit. 0% 5% 90% 2% Acute Appendicitis

+ What Influences our Decision Thresholds: A Review Physician expertise Health system Intervention Prior experience Patient preference

+ Diagnostic Options for Urolithiasis KUB (Kidney, Ureter, Bladder) Ultrasound Intravenous Pyelography

+ Diagnostic Dilemma What is the sensitivity and specificity of KUB Ultrasound vs Intravenous Pyelography in diagnosing Urolithiasis using Cross-Sectional Studies?

+

+

+

+

+

+

+

+

+

+

+ CRITICAL APPRAISAL Is the study valid?

+ PRIMARY VALIDITY GUIDES 1. Was there an independent and blind comparison with a reference standard? YES. All of the 108 patients enrolled in the study first underwent KUB-UTZ then Intravenous Pyelography (the criterion standard). A reference standard for a diagnostic test is the test that gives the information nearest to the “truth”. Thus the accuracy of the test should be compared against the standard.

+ PRIMARY VALIDITY GUIDES 2. Did the patient sample include the spectrum of patients to whom the test will be applied in practice? YES. The patients enrolled in the study were adult patients between the ages of 18 and 65 years presenting with unilateral flank pain and hematuria who presented at the Emergency Department. The patient in our case was a 25-year-old female, presenting with R flank pain and hematuria, who went for consult at AMBU. The accuracy of a diagnostic test among patients with low risk for the disease is different from patients with high risk of the disease.

+ SECONDARY VALIDITY GUIDES 3. Was the reference standard done regardless of the result of the diagnostic test being evaluated? YES. All 108 patients included in the study underwent both KUB- UTZ and Intravenous Pyelography regardless of the result of each test. VERIFICATION BIAS: In some studies, the reference standard (in this case, IVP) is only done based on the initial result of the diagnostic test (KUB-UTZ) in order to verify the initial finding, i.e., when positive. When this happens, most of the data available will be those positive for the diagnostic test and the reference standard. This will increase the accuracy of the test.

+ SECONDARY VALIDITY GUIDES 4. Were the methods for performing the test described in sufficient detail to permit replication? YES. The procedures (KUB-Ultrasound and IVP) were described in detail in the methods section.

+ OVERALL, IS THE STUDY VALID? YES. Most of the questions were answered adequately.

+ CRITICAL APPRAISAL What are the results?

+ RESULTS 1. What were the likelihood ratios for the different possible test results? Likelihood ratios indicate by how much a given test result increases the pre-test probability of the disease. 5%0%75% 60% Urolithiasis

+ Likelihood Ratios for the Diagnostic Test (KUB-UTZ) Positive Test LR (+) = Sn/1-Sp / (1 – 0.589) / Negative Test LR (-) = 1-Sn/Sp (1 – 0.971) / /

+ Nomogram for interpreting diagnostic test results (Likelihood ratio) In this nomogram, a straight line drawn from a patient's pre-test probability of disease (which is estimated from experience, local data or published literature) through the LR for the test result that may be used, will point to the post-test probability of disease.

+ Post-test Probabilities after KUB- UTZ 82% now falls on the decision to treat limit. Therefore, a positive KUB-UTZ result can boost your decision to start treatment already. However, a negative KUB-UTZ result is not enough to make you decide to send your patient home because it is still above the lower limit of our decision threshold. 60% Urolithiasis 0%5%75% 7%82% (-) (+)

+ CRITICAL APPRAISAL Will the results help me in caring for my patients?

+ Will the reproducibility of the test result and its interpretation be satisfactory in my setting? YES. KUB-UTZ is widely used in our setting. It was also adequately described in the study and its interpretation was definite and simple.

+ Are the results applicable to my patient? YES. Patients included in the study are those between the ages of 18 and 65 years who presented at the Emergency Department with unilateral flank pain and hematuria. Our patient is a 25-year-old female who presented at AMBU with R flank pain, hematuria, and frequency.

+ Will the results change my management? YES. If the KUB-UTZ is positive, the post-test probability increases to 82%, which falls into the range for a decision to start treatment.

+ Will patients be better off as a result of the test? YES. Doing the test will help us in deciding whether to start treatment.

+ Resolution of the Problem in the Scenario KUB-UTZ has a high sensitivity and can be used as an effective screening tool in the evaluation of adult patients presenting with unilateral flank pain and hematuria.